Screening for diabetes among tuberculosis patients: a nationwide population-based study in Egypt by Gadallah, Mohsen et al.
Screening for diabetes among tuberculosis patients: a nationwide 
population-based study in Egypt
Mohsen Gadallah1, Wagdy Amin2, Magdy Fawzy2, Alaa Mokhtar2, Amira Mohsen3
1. Community, Environmental and Occupational Medicine. Faculty of  Medicine - Ain Shams University, Cairo 
    11566 Egypt.
2. Ministry of  Health and Population - Chest Directorate, National Tuberculosis Control Program, Cairo, Egypt.
3. National Research Center, Cairo, Egypt, Department of  Community Medicine, Cairo, Egypt.
Abstract
Background: The prevalence of  type 2 diabetes mellitus (DM) is increasing rapidly in Egypt and considered one of  the major 
health problems in the Eastern Mediterranean region. 
Objectives: To measure the prevalence of  diabetes and detect the undiagnosed cases of  diabetes mellitus among patient with 
tuberculosis. 
Methods: Study Design: Nationwide population-based study. To diagnose DM among TB patients, we used a fasting blood 
sugar level of  ≥ 126 mg/dl and a post-prandial blood glucose test result of  ≥ 200 mg/dl. 
Results: Screening for DM among 1435 TB patients' with no history of  DM detected 30 new cases of  DM, with a case detection 
rate of  2.09%. The highest screening yields were among TB patients aged ≥ 40 years, females and those with pulmonary TB. The 
number needed to screen (NNS) TB patients for detecting one new case of  DM was 48 while the lowest values were for older 
age (NNS=27) and females (NNS=29). 
Conclusion: Older age and being females and those with pulmonary type of  TB were more prone to the double burden of  TB 
and DM. Identifying cases with double burden of  diseases will improve the proper management of  both diseases and prevent 
complications.  
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Diabetes mellitus (DM) affected 422 million adults and 
killed 5.1 million people. In 2013, there were an estimated 
9.6 million incident cases of  TB and 1.5 million TB-relat-
ed deaths globally. It is projected that the number of  peo-
ple affected by DM will increase to 592 million by 2035, 
and approximately 80% of  these people live in low- and 
middle-income countries, where TB is endemic.1,2 The as-
sociation between TB and DM is re-emerging in particu-
larly in low and low-middle income countries during the 
past decade. Many systematic reviews confirmed the sig-
nificant evidence between TB and MD co-morbidity and 
they reported that  DM patients have a three-fold greater 
risk of  contracting TB than do non-diabetics (95% confi-
dence interval [CI]: 2.3–4.3) while the prevalence of  DM 
among TB patients ranged between 1.9% and 45% with 
median global value of  16%. The tremendous increase in 
the prevalence of  DM in developing countries will reflect 
inversely on the successful control of  TB especially in 
countries with high burden of  both diseases.3-5 
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In Egypt, the prevalence of  DM among those aged from 
15 to 64 years increased from 15.8% in 2005 to 17.2% 
in 2011-12. Accordingly, a large proportion of  Egyptians 
will be exposed to high risk of  acquiring TB. Moreover, in 
Egypt Gadallah et al6 reported that patients with both TB 
and DM were more likely to develop complication than 
TB patients without DM. There is no national survey in 
Egypt to address the significant link between DM and TB. 
In this study, we describe the feasibility of  implementing 
a screening program to screen TB patients for DM within 
all governmental TB control and management units. The 
objectives of  this study were to measure the prevalence 
of  known diabetes among TB patients, detect new cases 
of  DM and to estimate the necessary number to screen 
TB patients to find a new case of  DM.
Methods
Study design: This was a nationwide population–based 
study. 
Study population:
TB patients (all forms) newly diagnosed and recorded 
in all TB management units in Egypt during the fourth 
quarter of  2012 (1745 patients) were included, and their 
diabetes status was determined. Only TB patients' aged 
≥18 years were included in the study (1608 patients). Di-
agnosis of  TB either pulmonary or extra pulmonary was 
based on the national tuberculosis control guidelines. Pul-
monary TB (PTB) was diagnosed when at least two spu-
tum smear examinations were positive for acid-fast bacilli 
(AFB) or one smear examination positive for AFB and 
x-ray chest showed radiographic abnormalities consistent 
with active TB as determined by a chest specialist. Extra 
pulmonary TB (EPTB) was made by identifying AFBs in 
organs other than lung diagnosed histologically and/or 
culture with clinical evidence of  active EPTB. 
Diagnosis of  DM: 
Patients with TB were first asked whether they had DM. 
If  the answer was yes (i.e., a self-reported history of  tak-
ing anti-diabetic drugs after being diagnosed by a medi-
cal professional), then the patient considered to have an 
established case of  DM (known DM). When the answer 
was no, they were screened using fasting blood glucose 
(FBG) and 2-hour blood glucose tests. Those with a FBG 
test result of  ≥126 mg/dl and a post-prandial blood glu-
cose (PPBG) test result of  ≥ 200 mg/dl were considered 
positive for DM (newly detected DM). Blood glucose was 
analyzed using semi-automated photometer 5010, manu-
factured by RIELE, GmbH &Co KG, Berlin-Germany, 
2012.
 
Data collection tool and variables:
Physicians working in all TB management units were 
trained to collect study data variables related to the study 
objectives from TB register and patient cards. In addition, 
a simple questionnaire was designed to collect data about 
the other study variables. Laboratory technician was re-
sponsible for withdrawing blood from TB patients and 
carried out the both FBG and PPBG. The key variables 
included: age, gender, place of  residence, history of  dia-
betes and type of  TB.
Operational definition of  study variables and out-
come:
Known DM cases: Are those TB patients with previous 
history of  DM and under current treatment of  diabetes.
Screen Detection New Cases: Are those TB patients 
with unknown DM status or gave no history of  DM and 
but positive by screening test.
Total prevalence: All TB patients with known diabetes 
and the new detected cases by screening.
Ethical approval
The protocol of  the study was approved by the Institu-
tional Review Board (IRB) of  the faculty of  medicine, 
Ain Shams University. All patient data were kept confi-
dential. Informed consent was obtained from each pa-
tient included in the study after having been given a clear 
description of  the study objectives. New diabetic patients 
detected by the screening were referred to specialized 
clinics for further management.
Statistical analysis:
All data were analyzed using SPSS version 21. Chi-square 
test or Fisher's exact test were applied for qualitative vari-
ables. For all study variables; 95% CI were applied. For 
calculation of  the number needed to screen (NNS) was 
calculated as the reciprocal of  the case detection rate. 
Additional yield percent was calculated as follow number 
of  new of  DM detected by screening divided by total 
number of  known and new cases of  DM multiplied by 
100. Multivariable logistic regression models were used 
for identifying the predictor variables associated with the 
total prevalence and screened detection new cases of  DM 
among TB patients. A P value of  ≤ 0.05 was considered 
significant.
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Results
Screening for DM among TB patients
The total number of  TB cases notified in the fourth quar-
ter of  2013 was 1,745 patients. In this study only patient 
aged ≥ 18 years old were included. Of  1608 TB patients 
included in the study, 173 (10.76%, 95%CI=(9.34–12.37) 
had previously been diagnosed with DM. Screening of  
the remaining 1435 TB patients detected 30 newly diag-
nosed cases of  DM, with a screening detection rate of  
2.09% (95%CI=1.47–2.97) . The prevalence (known di-
abetics) and detection rates were re-calculated across the 
patient characteristics (tables 1 and 2).
Table (1) Prevalence of known DM among TB patients 
 
  Total sample 
  
Known DM Prevalence of known 
DM 
(95% CI) 
Total 1608 173 10.76 (9.34–12.37) 
Age     
      < 30 
     30–39 














     Male 
    Female 
  
1132 








     Urban 










Site of TB 
   EPTB 
   PTB 
  
  373 
1235 
  







The highest prevalence of  known DM (19.92%) was 
reported among older age (≥ 40 years old) and among 
females (14.92%). Similarly, the highest screen detec-
tion rate was found among older age group (3.69%) and 
among females (3.46%).
After excluding previously diagnosed DM cases, the 
NNS to detect a new case of  DM among TB patients was 
48. The lowest NNS values were found among TB pa-
tients aged ≥ 40 years (NNS=27) and female TB patients 
(NNS=29), while the highest NNS value was reported 
among TB patients aged less than 30 years (NNS=483).
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Table (2) Screen detection rate of new cases of DM among TB patients 



















Total 1435 30 2.09 (1.47–2.97) 14.8 48 
Age     
      < 30 
     30–39 






















     Male 

















     Urban 
















Site of TB 
   EPTB 
















         # NA= Not Applicable for calculation 
Factors associated with knownDM cases and new DM 
cases detected by screening among TB patients are dis-
played in tables 3 and 4. The results of  the bivariate anal-
yses showed that an age of  30–40 and ≥ 40 years old, 
the female gender and the presence of  pulmonary TB 
(PTB) were significantly associated with known DM. The 
same variables remained significant after applying a multi-
variable logistic regression.  As regards factors associated 
with screen detection rate, the bivariate analysis showed 
that only those in the age groups of  30–40 and ≥ 40 years 
old and the female gender were significantly associated 
with newly detected cases of  DM. The same variables 
remained in the final model of  the multivariate logistic 
analysis.  
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Table (3) the relation between patient characteristics and the total prevalence 




Total prevalence of DM (n=203) 
P value Unadjusted OR 
 (95% CI) 
P value Adjusted OR  
(95% CI) 
Age     
      < 30® 
     30–39 







3.17 (1.35–7.43)  










     Male® 














     Rural® 













Site of TB 
     EPTB® 













         ® Reference group 
  
 
Table (4) the relation between patient characteristics and new detection  




Newly detected DM cases (n=30) 
P value Unadjusted OR 
(95% CI) 
P value Adjusted OR 
(95% CI) 
Age     
      < 30® 
     30–39 


















     Male® 












3.53 (1.63–7.64)  
Residence 
     Rural® 












1.52 (0.72- 3.21) 
Site of TB 
    EPTB® 













        ® Reference group 
Discussion
This study is considered the first documented nation-
al-based survey for implementing bi-directional screening 
for DM and TB in Egypt. All patients with active TB (≥ 
18 years) registered in the fourth quarter of  2012 from all 
TB clinics/hospitals in Egypt had been subjected to DM 
screening. The total prevalence was 12.6%, which is still 
lower than the national figure obtained from the national 
stepwise survey in 2012 (17.2%). This lower prevalence 
rate among our TB patients might be explained by the 
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higher proportion of  males in our study (70%) compared 
with the proportion of  51% in the study population of  
the Egypt stepwise survey. Another explanation for the 
low prevalence of  DM among the study population is 
the method of  DM diagnosis; in our study, we depended 
upon measuring both FBS and PPBS levels, while in the 
stepwise survey, only FBS was used. Similar to our re-
sults; Li et al7 reported a DM prevalence of  12.4% among 
TB patients in China, while in contrast with our results, 
higher prevalence rates were reported in India and Ethio-
pia.8-10 Moreover,the prevalence of  DM was significantly 
associated with older age groups. In agreement to our re-
sults; many studies have found a significantly higher prev-
alence of  DM among those aged ≥ 40 years.3,8-11 Regard-
ing the association between gender and the prevalence 
of  DM among TB patients, the current study showed 
a significant higher prevalence of  DM among females 
even after adjusting for other confounder factors. There 
is no consensus about sex and the prevalence of  DM as 
some studies have reported a higher prevalence among 
males8,11, 12, while other studies have reported the reverse10 
while many researches did not find any association.13-16
Our results revealed that the prevalence of  DM was sig-
nificantly higher among PTB patients than extra-pulmo-
nary TB (EPTB) patients, which is consistent with other 
studies performed in India8,11,16, Ethiopia10, and Sri Lan-
ka12. The association between PTB and DM might be re-
lated to the temporary elevation of  blood sugar due to 
infection with TB. Because our study was cross-section-
al, the existence of  this temporal effect is uncertain and 
could not be determined. Therefore, it is recommended 
that future studies monitor blood sugar during the course 
of  TB treatment to avoid a false-positive diagnosis of  
DM, if  the screening is performed only at the beginning 
of  the treatment.
The screening of  TB patients with an unknown history 
of  DM showed a case detection rate of  2.09%, yielding 
approximately a 15% increase in the prevalence of  DM. 
The case detection rate was significantly higher among 
the female gender, those aged ≥ 40 years and those with 
PTB. In this study, in order to detect a new case of  DM 
among TB patients, we needed to screen 48 patients. The 
NNS in the current study ranged between 27 (for patients 
aged ≥ 40 years) and 483 (for TB patients younger than 30 
years). This finding is much higher than what was report-
ed in other studies in India, Ethiopia, Sri Lanka, Kenya, 
Peru, Nigeria and China.8,10,12,14,17-19. This difference might 
be attributable to the prevalence of  DM in the general 
population of  each country, age composition differences 
and the methods used for DM diagnosis. 
Conclusion
The prevalence of  DM among TB patients was quite low-
er than the national figure. The factors associated with 
the total prevalence of  DM and the detection rate of  new 
cases were older age and females and among those with 
pulmonary type of  TB. The NNS was higher than many 
published articles.
There are some limitations of  this study. The study sample 
used for screening TB patients for detection of  diabetes 
among them was limited to patients seen in one quarter 
of  the year. This study is considered a cross-sectional one 
with its disadvantage of  temporal effect. Also, we did not 
measure the anthropometric parameters due to lacking 
of  standardized weigh scales in most of  study sites. Oth-
er limitations included lacking questions related physical 
exercise and family history of  DM. The strengths of  this 
study are; it is the first national base study to assess the 
prevalence of  diabetes among TB patients and proved 
the feasibility to conduct such screening test for DM in all 
TB management clinics all over the country.   
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